ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

March 5, 2010

NCI-Approved CTEP Trials For the Month of December

December 28, 2012

Senate Subcommittee Agrees On $1.188 Billion NCI Budgt for FY 1985, $110 Million Increase Over ‘84

June 29, 1984

Cancer Center In Russia Seeks Cancer Drugs, Other Supplies, From US

July 30, 1993

In Brief: No Decision Yet On How CALB Cuts Will Be Made; Wyngaarden Of Duke Will Be New Director of NIH

January 29, 1982

In Brief: Longmire Reappointed to Panel; New Organ System Group For Brain-CNS Tumors Asked

April 26, 1985